Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000925814 | SCV001071366 | likely benign | not provided | 2025-01-15 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000925814 | SCV004153026 | likely benign | not provided | 2023-10-01 | criteria provided, single submitter | clinical testing | NFKB1: BP4, BP7 |
Breakthrough Genomics, |
RCV000925814 | SCV005260258 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV003933138 | SCV004752130 | likely benign | NFKB1-related disorder | 2019-07-01 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |